NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE121175 Query DataSets for GSE121175
Status Public on Dec 31, 2018
Title Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Homoharringtonine (HHT), a previously known protein synthesis inhibitor, has anti-myeloid leukemia effect and potentiates the therapeutic efficacy of anthracycline/cytarabine induction regimens for acute myeloid leukemia (AML) with favorable and intermediate prognosis, especially in t(8;21) subtype. Here we provide evidence to show that HHT inhibits the activity of leukemia-initiating cells (Lin-/Sca-1-/c-kit+, LICs) in t(8;21) murine leukemia model and exerts down-regulating effect on MYC pathway genes in human t(8;21) leukemia cells (Kasumi-1). By using biochemistry approach, NF-κB-repressing factor (NKRF) was discovered to be bound directly by HHT via the second double-strand RNA binding motif (DSRM2) domain, which is the nuclear localization signal (NLS) of NKRF. A series of deletion and mutagenesis experiments mapped HHT direct binding site to K479 and C480 amino acids in the DSRM2 domain. HHT treatment shifts NKRF from nucleus (including nucleoli) to cytoplasm through occupying the DSRM2 domain, strengthens p65-NKRF interaction, and interferes with the p65-p50 complex formation, thereby attenuating the transactivation activity of p65 on MYC gene. Moreover, HHT significantly decreases the expression of KIT, a frequently mutated and/or highly expressed gene in t(8;21) AML, in consistence with MYC downregulation. Our work has thus identified a mechanism different to, but in concert with, the classical mode of action of HHT and justifies its further clinical exploration in the treatment of AML.
 
Overall design Kasumi-1 cells vehicle; Kasumi-1 cells treated with 20 nM HHT for 24h
 
Contributor(s) CHEN X, ZHANG W, CHEN B, XI W, LU Y, HUANG J, WANG Y, LONG J, WU S, ZHANG Y, WANG S, LI S, YIN T, LU M, XI X, LI J, WANG K, CHEN Z, CHEN S
Citation(s) 30659143
Submission date Oct 12, 2018
Last update date Apr 01, 2019
Contact name Xinjie Chen
Organization name Shanghai Institute of Hematology
Street address RUIJIN ER ROAD
City SHANGHAI
State/province SHANGHAI
ZIP/Postal code 210000
Country China
 
Platforms (1)
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (6)
GSM3427357 SAMPLE 1_CON1
GSM3427358 SAMPLE 2_CON2
GSM3427359 SAMPLE 3_CON3
Relations
BioProject PRJNA495949

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE121175_RAW.tar 29.2 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap